Lisa Boggio to Hemophilia B
This is a "connection" page, showing publications Lisa Boggio has written about Hemophilia B.
Connection Strength
0.506
-
High adherence to prophylaxis regimens in haemophilia B patients receiving rIX-FP: Evidence from clinical trials and real-world practice. Haemophilia. 2020 Jul; 26(4):637-642.
Score: 0.183
-
PERSEPT 1: a phase 3 trial of activated eptacog beta for on-demand treatment of haemophilia inhibitor-related bleeding. Haemophilia. 2017 Nov; 23(6):832-843.
Score: 0.150
-
Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial. Blood. 2016 04 07; 127(14):1761-9.
Score: 0.134
-
Patient-reported outcomes and joint status across subgroups of US adults with hemophilia with varying characteristics: Results from the Pain, Functional Impairment, and Quality of Life (P-FiQ) study. Eur J Haematol. 2018 Apr; 100 Suppl 1:14-24.
Score: 0.039